TABLE 2.
Antifungal agent | Isolate | RSA incubation time (h) | Optimal inoculum dilution range for the RSAa | MICRSA range (μg/ml) for optimal inoculum dilutions | Published (μg/ml)b MIC range |
---|---|---|---|---|---|
Amphotericin B | C. albicans ATCC 24433 | 6 | 1/8 | 0.25 | 0.25–1.0 |
19 | 1/512–1/8192 | 0.125–0.25 | |||
C. albicans ATCC 90028 | 6 | 1/8 | 0.5 | 0.5–2.0 | |
19 | 1/8–1/8192 | 0.5 | |||
C. tropicalis ATCC 750 | 6 | 1/8 | 0.5 | 0.5–2.0 | |
19 | 1/8–1/8192 | 0.5 | |||
C. krusei ATCC 6258 | 6 | 1/8 | 1.0 | 0.5–2.0 | |
19 | 1/8–1/2048 | 0.5–1.0 | |||
C. parapsilosis ATCC 22019 | 6 | 1/8 | 1.0 | 0.25–1.0 | |
19 | 1/2–1/128 | 0.5–1.0 | |||
C. parapsilosis ATCC 90018 | 6 | 1/2–1/8 | 0.5–1.0 | 0.5–2.0 | |
19 | 1/2–1/128 | 0.5–1.0 | |||
Fluconazole | C. albicans ATCC 24433 | 6 | NDc | 0.25–1.0 | |
19 | 1/512–1/8192 | 0.5 | |||
C. albicans ATCC 90028 | 6 | ND | 0.25–1.0 | ||
19 | 1/512–1/8192 | 0.5–1.0 | |||
C. tropicalis ATCC 750 | 6 | 1/8 | 1.0 | 1.0–4.0 | |
19 | 1/512–1/8192 | 1.0–2.0 | |||
C. krusei ATCC 6258 | 6 | ND | 16.0–64.0 | ||
19 | 1/512–1/2048 | 32–64 | |||
C. parapsilosis ATCC 22019 | 6 | ND | 2.0–8.0 | ||
19 | 1/8–1/128 | 2.0–4.0 | |||
C. parapsilosis ATCC 90018 | 6 | ND | 0.25–1.0 | ||
19 | 1/8–1/128 | 1.0 |
The greatest inoculum dilution range across which the endpoint was stable within two consecutive drug concentrations.
Obtained from reference 11.
ND, no dilution evaluated filled the criteria; thus, a determination of an optimal inoculum for the RSA could not be made.